Allurion Technologies Inc.

ALUR

NYSE

Healthcare

Medical - Devices

Natick, MA, US134 employeesallurion.com

$0.78

+0.05(6.83%)

Mkt Cap $6M

$0.26

$3.26

52-Week Range

At a Glance

AI-generated

FY2025 delivered revenue of $15.2M (-52.6% YoY) and gross profit of $9.6M (-55.5%) from strategic sales shifts including B2B2C transition, distributor changes, and French suspension, with operating losses narrowing 39.9% to -$30.2M on cost discipline amid deepening net losses to -$28.8M.

8-K

Allurion Technologies Inc. received a notice from the New York Stock Exchange on March 6, 2026, regarding delisting or failure to satisfy a continued listing rule or standard for its Common Stock and Warrants. On March 12, 2026, the Company issued a press release in connection with the delisting notice.

$6M

Market Cap

$2M

Revenue

-$4M

Net Income

Employees134

Fundamentals

How The Business Makes Money

Revenue by Geography

All Other Countries77.4%($37M)

ES13%($6M)

IT9.6%($5M)

Activity

What Changed Recently

Delisting

Mar 11, 2026

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On March 6, 2026, the New York Stock Exchange (“NYSE”) noti

Delisting

Mar 1, 2026

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On March 2, 2026, Allurion Technologies, Inc., a Delaware co

Material Agreement

Feb 24, 2026

is incorporated herein by reference. Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Description 4.1 Form of New Warrant 10.1 Form of Induceme

Financial Results

Jan 11, 2026

of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed to be “filed” for purposes of Se

Regulation FD

Feb 22, 2026

of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished pursuant to Item 7.01 and shall not be deemed “filed” for purpose

Peer Companies

Company	Price	Change	Market Cap	P/E
ADAPADAP	$0.05	-3.00%	$75M	—
COCHEnvoy Medical, Inc.	$0.76	+7.62%	$16M	-0.6
LFWDLifeward Ltd.	$6.85	+0.74%	$10M	-0.5
VVOSVivos Therapeutics, Inc.	$1.33	+2.11%	$8M	-0.8
XAIRBeyond Air, Inc.	$0.70	-1.99%	$4M	-0.2
CODXCo-Diagnostics, Inc.	$1.55	-4.32%	$2M	—
AEMDAethlon Medical, Inc.	$2.14	-0.47%	$2M	-0.2
ERNAErnexa Therapeutics Inc. ...	$0.20	-3.14%	$2M	-0.1

Analyst View

Company Profile

CIK0001964979

ISINUS02008G2012

CUSIP02008G102

Phone508 647 4000

Address11 Huron Drive, Natick, MA, 01760, US

SEC EDGAR